[HTML][HTML] Tumor microenvironment mechanisms and bone metastatic disease progression of prostate cancer
During disease progression from primary towards metastatic prostate cancer (PCa), and in
particular bone metastases, the tumor microenvironment (TME) evolves in parallel with the …
particular bone metastases, the tumor microenvironment (TME) evolves in parallel with the …
[HTML][HTML] The fight against cancer by microgravity: The multicellular spheroid as a metastasis model
Cancer is a disease exhibiting uncontrollable cell growth and spreading to other parts of the
organism. It is a heavy, worldwide burden for mankind with high morbidity and mortality …
organism. It is a heavy, worldwide burden for mankind with high morbidity and mortality …
Genomic analysis of circulating tumor DNA in 3,334 patients with advanced prostate cancer identifies targetable BRCA alterations and AR resistance mechanisms
H Tukachinsky, RW Madison, JH Chung… - Clinical Cancer …, 2021 - AACR
Purpose: Comprehensive genomic profiling (CGP) is of increasing value for patients with
metastatic castration-resistant prostate cancer (mCRPC). mCRPC tends to metastasize to …
metastatic castration-resistant prostate cancer (mCRPC). mCRPC tends to metastasize to …
Impact of the site of metastases on survival in patients with metastatic prostate cancer
G Gandaglia, PI Karakiewicz, A Briganti, NM Passoni… - European urology, 2015 - Elsevier
Background Limited data exist on the impact of the site of metastases on survival in patients
with stage IV prostate cancer (PCa). Objective To investigate the role of metastatic …
with stage IV prostate cancer (PCa). Objective To investigate the role of metastatic …
Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years
Abstract Background Prostate cancer (PCa) patients with lymph node recurrence after
radical prostatectomy (RP) are usually managed with androgen-deprivation therapy. Despite …
radical prostatectomy (RP) are usually managed with androgen-deprivation therapy. Despite …
[HTML][HTML] PSMA PET-CT in the Diagnosis and Staging of Prostate Cancer
AD Combes, CA Palma, R Calopedos, L Wen, H Woo… - Diagnostics, 2022 - mdpi.com
Prostate cancer is the most common cancer and the second leading cause of cancer death
in men. The imaging assessment and treatment of prostate cancer has vastly improved over …
in men. The imaging assessment and treatment of prostate cancer has vastly improved over …
Accelerating precision medicine in metastatic prostate cancer
Despite advances in the screening and treatment of prostate cancer, the therapy options
available, particularly for later stages of the disease, remain limited, and the treatment …
available, particularly for later stages of the disease, remain limited, and the treatment …
[HTML][HTML] The nerve growth factor-delivered signals in prostate cancer and its associated microenvironment: When the dialogue replaces the monologue
M Di Donato, P Giovannelli, A Migliaccio, G Castoria - Cell & Bioscience, 2023 - Springer
Prostate cancer (PC) represents the most diagnosed and the second most lethal cancer in
men worldwide. Its development and progression occur in concert with alterations in the …
men worldwide. Its development and progression occur in concert with alterations in the …
68Ga-PSMA PET/CT replacing bone scan in the initial staging of skeletal metastasis in prostate cancer: a fait accompli?
T Lengana, IO Lawal, TG Boshomane… - Clinical genitourinary …, 2018 - Elsevier
Purpose 68 Ga ligands targeting prostate-specific membrane antigen (PSMA) are rapidly
emerging as a significant step forward in the management of prostate cancer. PSMA is a …
emerging as a significant step forward in the management of prostate cancer. PSMA is a …
Prostate-specific membrane antigen (PSMA)-targeted PET imaging of prostate cancer: an update on important pitfalls
The continuing adoption of prostate specific membrane antigen (PSMA)-targeted PET for
prostate cancer molecular imaging requires imagers and clinicians alike to be aware of the …
prostate cancer molecular imaging requires imagers and clinicians alike to be aware of the …